BMC Musculoskeletal Disorders

official impact factor 1.94

Open Access Highly Access Pre-publication history

S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial. [ISRCTN36233495]

Wadie I Najm*, Sibylle Reinsch, Fred Hoehler, Jerome S Tobis and Phillip W Harvey

BMC Musculoskeletal Disorders 2004, 5:6 doi:10.1186/1471-2474-5-6

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 22 Jul 2003
Reviewer's Report Betsy Singh 05 Aug 2003
Reviewer's Report David Scott 14 Aug 2003
Reviewer's Report Teodoro Bottiglieri 05 Sep 2003
Resubmission - Version 2 Manuscript Author's comment 17 Sep 2003
Resubmission - Version 3 Manuscript Author's comment 08 Jan 2004
Reviewer's Report Teodoro Bottiglieri 29 Jan 2004
Published 26 Feb 2004